See the Full Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eurovision
Baseball
Social Media
Natural Disasters
European Union
South America
Donald Trump
Soccer
Artificial Intelligence
Boxing
Vladimir Putin
Premier League
Published • loading... • Updated

Bluebird extends deal deadline; Affimed files for insolvency

Summary by biopharmadive.com
Shareholders in Bluebird now have a choice of two offers from would-be acquirers Carlyle and SK Capital. Elsewhere, Cytokinetics shared more aficamten data and BridgeBio started a new kind of Attruby trial.

1 Articles

All
Left
Center
1
Right
biopharmadive.combiopharmadive.com
Center

Bluebird extends deal deadline; Affimed files for insolvency

Shareholders in Bluebird now have a choice of two offers from would-be acquirers Carlyle and SK Capital. Elsewhere, Cytokinetics shared more aficamten data and BridgeBio started a new kind of Attruby trial.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news in on Wednesday, May 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal